CRISPR/Cas9 Knockout Plasmids
Wide range of CRISPR knockout and activation products
Santa Cruz Biotechnology launches advanced VE-cadherin antibodies to empower vascular biology research in the BeNeLux—available now via Bio-Connect.
Santa Cruz Biotechnology (SCBT), a global leader in research antibodies, is proud to introduce its latest selection of VE-cadherin antibodies—now available through Bio-Connect for researchers and professionals in the BeNeLux. These cutting-edge antibodies offer exceptional specificity and performance for the study of vascular biology, endothelial cell research, and related disease models.
VE-cadherin, also known as cadherin-5 or CD144, is a calcium-dependent adhesion molecule exclusively expressed in endothelial cells. It plays a pivotal role in maintaining vascular integrity, regulating endothelial permeability, and controlling angiogenesis. As a key marker in vascular biology, VE-cadherin is widely studied in the context of cardiovascular disease, tumor metastasis, and inflammatory processes.
SCBT offers a comprehensive range of monoclonal and VE-cadherin antibodies validated for diverse applications such as Western blot (WB), immunofluorescence (IF), immunohistochemistry (IHC), and flow cytometry (FC). These antibodies are quality-tested to ensure reproducibility and consistent results across experiments.
With the growing importance of endothelial cell biology in vascular disease, cancer metastasis, and tissue engineering, reliable VE-cadherin antibodies are essential for accurate analysis. SCBT antibodies enable researchers to:
Bio-Connect ensures responsive local support, fast delivery, and expert advice for BeNeLux customers. By partnering with SCBT, Bio-Connect provides access to the latest antibody innovations, backed by SCBT’s global reputation for quality and performance.
For detailed product information and ordering, simply click the catalog numbers in the tables below to visit our webshop. For personal assistance, please contact your account manager.
Product Name | Catalog # |
---|---|
VE-cadherin CRISPR/Cas9 KO Plasmid (h) | sc-400063 |
VE-cadherin HDR Plasmid (h) | sc-400063-HDR |
VE-cadherin Double Nickase Plasmid (h) | sc-400063-NIC |
VE-cadherin Double Nickase Plasmid (h2) | sc-400063-NIC-2 |
VE-cadherin CRISPR/Cas9 KO Plasmid (m) | sc-419596 |
VE-cadherin HDR Plasmid (m) | sc-419596-HDR |
VE-cadherin Double Nickase Plasmid (m) | sc-419596-NIC |
VE-cadherin Double Nickase Plasmid (m2) | sc-419596-NIC-2 |
Product Name | Catalog # |
---|---|
VE-cadherin CRISPR Activation Plasmid (h) | sc-400063-ACT |
VE-cadherin CRISPR Activation Plasmid (h2) | sc-400063-ACT-2 |
VE-cadherin Lentiviral Activation Particles (h) | sc-400063-LAC |
VE-cadherin Lentiviral Activation Particles (h2) | sc-400063-LAC-2 |
VE-cadherin CRISPR Activation Plasmid (m) | sc-419596-ACT |
VE-cadherin CRISPR Activation Plasmid (m2) | sc-419596-ACT-2 |
VE-cadherin Lentiviral Activation Particles (m) | sc-419596-LAC |
VE-cadherin Lentiviral Activation Particles (m2) | sc-419596-LAC-2 |
Product Name | Catalog # |
---|---|
VE-cadherin siRNA (h) | sc-36814 |
VE-cadherin shRNA Plasmid (h) | sc-36814-SH |
VE-cadherin shRNA (h) Lentiviral Particles | sc-36814-V |
VE-cadherin siRNA (m) | sc-36813 |
VE-cadherin siRNA (m2) | sc-270282 |
VE-cadherin shRNA Plasmid (m) | sc-36813-SH |
VE-cadherin shRNA Plasmid (m2) | sc-270282-SH |
VE-cadherin shRNA (m) Lentiviral Particles | sc-36813-V |
VE-cadherin shRNA (m2) Lentiviral Particles | sc-270282-V |
VE-cadherin siRNA (S. scrofa) | sc-270464 |
VE-cadherin shRNA Plasmid (S. scrofa) | sc-270464-SH |
VE-cadherin shRNA (S. scrofa) Lentiviral Particles | sc-270464-V |
We gladly support you by keeping you updated on our latest products and the developments around our services.